Abel Torres, MD, JD, MBA, FAAD, FACMS

Chairman & Professor

Department: MD-DERMATOLOGY

Business Phone: (352) 594-1919

About Abel Torres

Dr. Torres is a clinician, researcher, educator and lawyer serving as chair of the University of Florida Department of Dermatology. He has Board Certification in Internal Medicine and Dermatology and Bar/Law License Certification and has devoted his career to tackling complex dermatologic conditions, providing excellent patient care, embarking on extensive research and training medical students, residents and fellows in both the clinical, surgical and legal areas of medicine.

He has led research on topics including the treatment of leg ulcers and burns, precancerous lesions such as actinic keratosis and skin cancer. Dr. Torres’ current research interests include establishing the role of topical immunomodulators in the treatment of skin cancers, as well as noninvasive techniques in skin cancer detection and surgery.

Dr. Torres completed an advanced International Dermatologic Surgery Fellowship at the University of Seville, Spain and a Dermatologic Surgery at the University of California at San Francisco where he received intensive training in Skin Cancer Surgery including Mohs Surgery and Reconstruction and Cosmetic Dermatologic Surgery. His Cosmetic Surgery training includes lasers, liposuction surgery, fillers, neuromodulators/Botox, micro and macrodermabrasion, microneedling, Platelet Rich Plasma (PRP), chemical peeling and more. He has since directed fellowship training programs training dermatologists and post training fellows at the Brigham and Woman’s Hospital/Harvard Medical School, Loma Linda University, Case Western Reserve University/MetroHealth Systems and most recently at the University of Florida Gainesville.

Accomplishments

Chairman & Professor of Dermatology

2018-Current · University of Florida, College of Medicine

President of the American Academy of Dermatology

2016-2017 · American Academy of Dermatology

Treasurer

2012-2015 · American Society for Dermatologic Surgery Board

Member of the Board of Directors, American Academy of Dermatology

2011-2014 · American Academy of Dermatology

Member of the Board of Directors, American Society for Dermatologic Surgery

2009-2012 · American Society for Dermatologic Surgery

Board Certifications

Dermatology

American Board of Dermatology
Mohs Fellowship Certificate

American College of Mohs Micrographic Surgery and Cutaneous Oncology

Clinical Profile

Specialties

Dermatology

Areas of Interest

Actinic keratosis
Burns
Mohs micrographic surgery
Skin Cancer

Publications

2023

Reducing Legal Risks and Social Media Issues for Cosmetic Surgery.

Facial plastic surgery clinics of North America. 31(2):333-340 [DOI] 10.1016/j.fsc.2023.01.017. [PMID] 37001936.

2 citations · PubMed · Publisher’s Site

2022

A Retrospective Review of Histopathologic Features Associated with Increased Risk of Recurrence of Non-melanoma Skin Cancer After Mohs Micrographic Surgery.

The Journal of clinical and aesthetic dermatology. 15(1):27-29 [PMID] 35309269.

PubMed

2020

Dermatology leadership and a top-down approach to increasing diversity.

Clinics in dermatology. 38(3):316-320 [DOI] 10.1016/j.clindermatol.2020.02.006. [PMID] 32563343.

8 citations · PubMed · Publisher’s Site

2020

Leukemia cutis mimicking tumid lupus as the presenting sign in a case of mixed T/B-cell acute lymphoblastic leukemia.

JAAD case reports. 6(7):598-602 [DOI] 10.1016/j.jdcr.2020.04.033. [PMID] 32685647.

4 citations · PubMed · Publisher’s Site

2018

Practicing Safe Dermatology-Screening Out Liability.

JAMA dermatology. 154(2):142-143 [DOI] 10.1001/jamadermatol.2017.4838. [PMID] 29214301.

PubMed · Publisher’s Site

2017

Commentary on Signs of Facial Aging in Men in a Diverse, Multinational Study: Timing and Preventive Behaviors.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 43 Suppl 2:S221-S224 [DOI] 10.1097/DSS.0000000000001379. [PMID] 29064989.

PubMed · Publisher’s Site

2016

Medicolegal issues.

Clinics in dermatology. 34(1):106-10 [DOI] 10.1016/j.clindermatol.2015.07.001. [PMID] 26773630.

2 citations · PubMed · Publisher’s Site

2007

Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream.

Journal of translational medicine. 5 [PMID] 17257431.

41 citations · PubMed

2004

5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 30(12 Pt 1):1462-9 [PMID] 15606733.

62 citations · PubMed

Grants

Oct 2020 – Feb 2022

Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in when used in Combination with Topical Corticosteroid Treatment in Patients with Moderate-to-Severe Atopic Dermatitis

Role: Principal Investigator

Funding: SYNEOS HEALTH via DERMIRA

Sep 2018 ACTIVE

A randomized, double-blind, vehicle-controlled multicenter phase III study to evaluate the safety and efficacy of BF-200 ALA (Ameluz) and BF-RhodoLED in the treatment of superficial basal cell carcinoma with photodynamic therapy

Role: Principal Investigator

Funding: BIOFRONTERA BIOSCIENCE GMBH